149
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Expression of Duffy antigen receptor for chemokines (DARC) is down-regulated in colorectal cancer

, , , , , & show all
Pages 462-467 | Received 16 Nov 2014, Accepted 07 Jan 2015, Published online: 22 Jun 2015

References

  • Jemal A, Bray F, Center MM, et al. Global cancer statistics. Cancer J Clinicians 2011;61:69–90
  • Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet 2014;383:1490–502
  • Fang Y-J, Wu X-J, Zhao Q, et al. Hospital-based colorectal cancer survival trend of different tumor locations from 1960s to 2000s. PloS One 2013;8:e73528
  • Zipin-Roitman A, Meshel T, Sagi-Assif O, et al. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells. Cancer Res 2007;67:3396–405
  • Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 2004;4:540–50
  • Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000;12:121–7
  • Langenes V, Svensson H, Börjesson L, et al. Expression of the chemokine decoy receptor D6 is decreased in colon adenocarcinomas. Cancer Immunol Immunother 2013;62:1687–95
  • Wang D, DuBois RN, Richmond A. The role of chemokines in intestinal inflammation and cancer. Curr Opin Pharmacol 2009;9:688–96
  • Murphy PM, Baggiolini M, Charo IF, et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000;52:145–76
  • Latini FRM, Bastos AU, Arnoni CP, et al. DARC (Duffy) and BCAM (Lutheran) reduced expression in thyroid cancer. Blood Cells Mol Dis 2013;50:161–5
  • Cutbush M, Mollison P, Parkin DM. A new human blood group. Nature 1950;165:188–9
  • Pruenster M, Rot A. Throwing light on DARC. Biochem Soc Trans 2006;34:1005–8
  • Horne K, Woolley IJ. Shedding light on DARC: the role of the Duffy antigen/receptor for chemokines in inflammation, infection and malignancy. Inflammation Res 2009;58:431–5
  • Wang J, Ou Z, Hou Y, et al. Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential. Oncogene 2006;25:7201–11
  • Zeng X-H, Ou Z-L, Yu K-D, et al. Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes. Breast Cancer Res Treatment 2011;125:715–27
  • Addison CL, Belperio JA, Burdick MD, Strieter RM. Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis. BMC Cancer 2004;4:28
  • Sun G, Wang Y, Zhu Y, et al. Duffy antigen receptor for chemokines in laryngeal squamous cell carcinoma as a negative regulator. Acta Oto-laryngol 2011;131:197–203
  • Stams WA, den Boer ML, Beverloo HB, et al. Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t (12; 21)+ pediatric ALL. Blood 2003;101:2743–7
  • Liang J-F, Wang H-K, Xiao H, et al. Research relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer. J Exp Clin Cancer Res 2010;29:71
  • Hou T, Liang D, Xu L, et al. Atypical chemokine receptors predict lymph node metastasis and prognosis in patients with cervical squamous cell cancer. Gynecol Oncol 2013;130:181–7
  • Zhu Z, Sun Z, Wang Z, et al. Prognostic impact of atypical chemokine receptor expression in patients with gastric cancer. J Surg Res 2013;183:177–83
  • Bailey C, Negus R, Morris A, et al. Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer. Clin Exp Metastasis 2007;24:121–30
  • Doll D, Keller L, Maak M, et al. Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and their impact on metastatic disease and survival. Int J Colorectal Dis 2010;25:573–81
  • McClellan JL, Davis JM, Steiner JL, et al. Physiology and GI Cancer: linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: role of MCP-1. Am J Physiol-Gastrointestinal Liver Physiol 2012;303:G1087
  • Ning Y, Manegold PC, Hong YK, et al. Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. Int J Cancer 2011;128:2038–49
  • Rubie C, Frick VO, Pfeil S, et al. Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer. World J Gastroenterol 2007;13:4996
  • Rubie C, Frick VO, Wagner M, et al. ELR+ CXC chemokine expression in benign and malignant colorectal conditions. BMC Cancer 2008;8:178
  • Speetjens FM, Kuppen PJ, Sandel MH, et al. Disrupted expression of CXCL5 in colorectal cancer is associated with rapid tumor formation in rats and poor prognosis in patients. Clin Cancer Res 2008;14:2276–84
  • Wang D, Wang H, Brown J, et al. CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J Exp Med 2006;203:941–51
  • Yoshidome H, Kohno H, Shida T, et al. Significance of monocyte chemoattractant protein-1 in angiogenesis and survival in colorectal liver metastases. Int J Oncol 2009;34:923–30
  • Bandyopadhyay S, Zhan R, Chaudhuri A, et al. Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression. Nat Med 2006;12:933–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.